Abstract
Chagas’ disease (CD), caused by the parasite Trypanosoma cruzi, is the leading cause of cardiac disability from infectious diseases in Central and South America. The disease progresses through an extended, asymptomatic form characterized by latency without clinical manifestations into a symptomatic form with cardiac and gastro-intestinal manifestations. In the terminal phase, chronic Chagas’ myocarditis results in extensive myocardial fibrosis, chamber enlargement with aneurysms and ventricular tachycardia (VT). Cardiac magnetic resonance imaging (CMR) has proven useful in characterizing myocardial fibrosis (MF). Sub-epicardial and mid-wall fibrosis are less common patterns of MF in CHD than transmural scar, which resembles myocardial infarction. Commonly involved areas of MF include the left ventricular apex and basal infero-lateral wall, suggesting a role for watershed ischemia in the pathophysiology of MF. Electrophysiology studies have helped refine the relationship between MF and VT in this setting. This article reviews the patterns of MF in CHD and correlate these patterns with electrogram patterns to predict risk of ventricular arrhythmias and sudden death.
Similar content being viewed by others
References
(2015) Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Relev Epidemiol Hebd 90(6):33–43
WHO | Disease burden and mortality estimates [Internet]. WHO. World Health Organization; 2018 [cited 2018 Apr 22]. Available from: https://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html
Ueno Y, Nakamura Y, Takahashi M, Inoue T, Endo S, Kinoshita M et al (1995) A highly suspected case of chronic Chagas’ heart disease diagnosed in Japan. Jpn Circ J 59(4):219–223
Sooklim K, Maskiell C, Brett NJ, Hansen M, Slaughter RE, Hamilton-Craig CR (2011) Chagas cardiomyopathy with left ventricular apical aneurysm: first case report in Australia. Intern Med J 41(12):846–848
Marcu CB, Beek AM, van Rossum AC (2007) Chagas’ heart disease diagnosed on MRI: the importance of patient ‘geographic’ history. Int J Cardiol 117(2):e58–60
Nunes MCP, Beaton A, Acquatella H, Bern C, Bolger AF, Echavarria LE et al (2018) Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association. Circulation 138:e169–e209
Rassi A, Rassi A, Marin-Neto JA (2010) Chagas disease. Lancet 375(9723):1388–1402
Ribeiro AL, Nunes MP, Teixeira MM, Rocha MOC (2012) Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol 9(10):576–589
Malik LH, Singh GD, Amsterdam EA (2015) The epidemiology, clinical manifestations, and management of Chagas heart disease. Clin Cardiol 38(9):565–569
Nunes MCP, Badano LP, Marin-Neto JA, Edvardsen T, Fernández-Golfín C, Bucciarelli-Ducci C et al (2018) Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging 19(4):459–460
Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF et al (2005) Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity. J Am Coll Cardiol 46(8):1553–1558
Andrade ZA, Andrade SG, Correa R, Sadigursky M, Ferrans VJ (1994) Myocardial changes in acute Trypanosoma cruzi infection: ultrastructural evidence of immune damage and the role of microangiopathy. Am J Pathol 144(6):1403–1411
Kumar R, Kline IK, Abelmann WH (1969) Experimental Trypanosoma cruzi myocarditis: relative effects upon the right and left ventricles. Am J Pathol 57(1):31–48
Bittencourt AL, Roters FA, da Silva HC (1990) Chronic Chagas cardiopathy in patients aged 12 to 15 years. Arq Bras Cardiol 55(5):301–303
Dias E, Laranja FS, Miranda A, Nobrega G (1956) Chagas’ disease; a clinical, epidemiologic, and pathologic study. Circulation 14(6):1035–1060
Milei J, Storino R, Fernandez Alonso G, Beigelman R, Vanzulli S, Ferrans VJ (1992) Endomyocardial biopsies in chronic Chagasic cardiomyopathy. Cardiology 80(5–6):424–437
Henao-Martínez AF, Schwartz DA, Yang IV (2012) Chagasic cardiomyopathy, from acute to chronic: is this mediated by host susceptibility factors? Trans R Soc Trop Med Hyg 106(9):521–527
Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, Carrara D et al (2001) Chronic Chagas’ disease cardiomyopathy patients display an increased IFN-γ response to Trypanosoma cruzi infection. J Autoimmun 17(1):99–107
Ferreira RC, Ianni BM, Abel LCJ, Buck P, Mady C, Kalil J et al (2003) Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/‘indeterminate’ and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 98(3):407–411
Araujo FF, Gomes JAS, Rocha MOC, Williams-Blangero S, Pinheiro VM, Morato MJF et al (2007) Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. Front Biosci 12:2797–2806
Cunha-Neto E, Chevillard C (2014) Chagas disease cardiomyopathy: immunopathology and genetics. Mediators Inflamm 2014:683230
Mello de Oliveira JA, Meira Oliveira JS, Köberle F (1972) Pathologic anatomy of the His-Tawara system and electrocardiographic abnormalities in chronic Chagas’ heart disease. Arq Bras Cardiol 25(1):17–25
Cruz JS, Machado FS, Ropert C, Roman-Campos D (2017) Molecular mechanisms of cardiac electromechanical remodeling during Chagas disease: role of TNF and TGF-β. Trends Cardiovasc Med 27(2):81–91
Higuchi ML, De Morais CF, Pereira Barreto AC, Lopes EA, Stolf N, Bellotti G et al (1987) The role of active myocarditis in the development of heart failure in chronic Chagas’ disease: a study based on endomyocardial biopsies. Clin Cardiol 10(11):665–670
Sadigursky M, Von Kreuter BF, Santos-Buch CA (1988) Development of chagasic autoimmune myocarditis associated with anti-idiotype reaction. Mem Inst Oswaldo Cruz 83(Suppl 1):363–366
Cunha-Neto E, Duranti M, Gruber A, Zingales B, de Messias I, Stolf N et al (1995) Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci United States Am 92(8):3541–3545
Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM (2006) Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 39:41–54
Rossi MA (1991) Patterns of myocardial fibrosis in idiopathic cardiomyopathies and chronic Chagasic cardiopathy. Can J Cardiol 7(7):287–294
Andrade Z, Lopes ER, Prata SP (1987) Changes in the heart conduction system in Chagasic patients suffering sudden death. Arq Bras Cardiol 48(1):5–9
Pimenta J, Miranda M, Silva LA (1979) Demonstration of re-entry in the His-Purkinje system in chronic Chagas’ disease: possible mechanisms of tachyarrhythmia. Arq Bras Cardiol 32(1):3–8
Tassi EM, Continentino MA, Nascimento EM, Pereira BB, Pedrosa RC (2014) Relationship between fibrosis and ventricular arrhythmias in Chagas heart disease without ventricular dysfunction. Arq Bras Cardiol 102(5):456–464
de Carvalho AC, Tanowitz HB, Wittner M, Dermietzel R, Roy C, Hertzberg EL et al (1992) Gap junction distribution is altered between cardiac myocytes infected with Trypanosoma cruzi. Circ Res 70(4):733–742
Waghabi MC, Coutinho-Silva R, Feige J-J, Higuchi ML, Becker D, Burnstock G et al (2009) Gap junction reduction in cardiomyocytes following transforming growth factor-β treatment and Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 104(8):1083–1090
Pacioretty LM, Barr SC, Han WP, Gilmour RF (1995) Reduction of the transient outward potassium current in a canine model of Chagas’ disease. Am J Physiol 268(3 Pt 2):H1258–H1264
Gadioli LP, Miranda CH, Pintya AO, de Figueiredo AB, Schmidt A, Maciel BC et al (2018) The severity of ventricular arrhythmia correlates with the extent of myocardial sympathetic denervation, but not with myocardial fibrosis extent in chronic Chagas cardiomyopathy: Chagas disease, denervation and arrhythmia. J Nucl Cardiol 25(1):75–83
Sousa AC, Marin-Neto JA, Maciel BC, Gallo Júnior L, Amorim DS, Barreto-Martins LE (1988) Systolic and diastolic dysfunction in the indeterminate, digestive and chronic cardiac forms of Chagas’ disease. Arq Bras Cardiol 50(5):293–299
Roman-Campos D, Sales-Júnior P, Duarte HL, Gomes ER, Guatimosim S, Ropert C et al (2013) Cardiomyocyte dysfunction during the chronic phase of Chagas disease. Mem Inst Oswaldo Cruz 108(2):243–245
Bestetti RB (2001) Predictors of unfavourable prognosis in chronic Chagas’ disease. Trop Med Int Health 6(6):476–483
Rochitte CE, Nacif MS, de Oliveira Júnior AC, Siqueira-Batista R, Marchiori E, Uellendahl M et al (2007) Cardiac magnetic resonance in Chagas’ disease. Artif Organs 31(4):259–267
Gagliardi MG, Bevilacqua M, Di Renzi P, Picardo S, Passariello R, Marcelletti C (1991) Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol 68(10):1089–1091
Kalil R, Bocchi EA, Ferreira BM, de Lourdes HM, Lopes NH, Magalhães AC et al (1995) Magnetic resonance imaging in chronic Chagas cardiopathy. Correlation with endomyocardial biopsy findings. Arq Bras Cardiol. 65(5):413–416
Bellotti G, Bocchi EA, de Moraes AV, Higuchi ML, Barbero-Marcial M, Sosa E et al (1996) In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas’ heart disease. Am Heart J 131(2):301–307
Regueiro A, García-Álvarez A, Sitges M, Ortiz-Pérez JT, De Caralt MT, Pinazo MJ et al (2013) Myocardial involvement in Chagas disease: insights from cardiac magnetic resonance. Int J Cardiol 165(1):107–112
Strauss DG, Cardoso S, Lima JAC, Rochitte CE, Wu KC (2011) ECG scar quantification correlates with cardiac magnetic resonance scar size and prognostic factors in Chagas’ disease. Heart 97(5):357–361
Rodríguez-Zanella H, Meléndez-Ramírez G, Velázquez L, Meave A, Alexanderson E (2015) ECG score correlates with myocardial fibrosis assessed by magnetic resonance: a study in Chagas heart disease. Int J Cardiol 187:78–79
Torreão JA, Ianni BM, Mady C, Naia E, Rassi CH, Nomura C et al (2015) Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 17(1):97
Assunção AN, Jerosch-Herold M, Melo RL, Mauricio AV, Rocha L, Torreão JA et al (2016) Chagas’ heart disease: gender differences in myocardial damage assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 18(1):88
Uellendahl M, de Siqueira MEM, Calado EB, Kalil-Filho R, Sobral D, Ribeiro C et al (2016) Cardiac magnetic resonance-verified myocardial fibrosis in chagas disease: clinical correlates and risk stratification. Arq Bras Cardiol 107(5):460–466
Noya-Rabelo MM, Macedo CT, Larocca T, Machado A, Pacheco T, Torreão J et al (2018) The presence and extension of myocardial fibrosis in the undetermined form of Chagas’ disease: a study using magnetic resonance. Arq Bras Cardiol. https://doi.org/10.5935/abc.20180016
Barizon GC, Simões MV, Schmidt A, Gadioli LP, Murta Junior LO (2020) Relationship between microvascular changes, autonomic denervation, and myocardial fibrosis in Chagas cardiomyopathy: evaluation by MRI and SPECT imaging. J Nucl Cardiol 27(2):434–444
Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U et al (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 72(24):3158–3176
de Sousa AS, Derenne ME, Hasslocher-Moreno AM, Xavier SS, Gottlieb I (2017) Myocardial edema without fibrosis by magnetic resonance T2 mapping in acute Chagas’ myocarditis. Arq Bras Cardiol 109(4):378–379
Belisario Falchetto E, Costa SCS, Rochitte CE (2015) Diagnostic challenges of Chagas cardiomyopathy and CMR imaging. Glob Heart 10(3):181–187
de Mello RP, Szarf G, Schvartzman PR, Nakano EM, Espinosa MM, Szejnfeld D et al (2012) Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas’ heart disease. Arq Bras Cardiol 98(5):421–430
Gomes VAM, Alves GF, Hadlich M, Azevedo CF, Pereira IM, Santos CRF et al (2016) Analysis of regional left ventricular strain in patients with Chagas disease and normal left ventricular systolic function. J Am Soc Echocardiogr 29(7):679–688
Lee-Felker SA, Thomas M, Felker ER, Traina M, Salih M, Hernandez S et al (2016) Value of cardiac MRI for evaluation of chronic Chagas disease cardiomyopathy. Clin Radiol 71(6):618.e1–7
Volpe GJ, Moreira HT, Trad HS, Wu KC, Braggion-Santos MF, Santos MK et al (2018) Left ventricular scar and prognosis in chronic chagas cardiomyopathy. J Am Coll Cardiol 72(21):2567–2576
Marin-Neto JA, Simões MV, Ayres-Neto EM, Attab-Santos JL, Gallo L, Amorim DS et al (1995) Studies of the coronary circulation in Chagas’ heart disease. Sao Paulo Med J 113(2):826–834
Marin-Neto JA, Marzullo P, Marcassa C, Gallo Júnior L, Maciel BC, Bellina CR et al (1992) Myocardial perfusion abnormalities in chronic Chagas’ disease as detected by thallium-201 scintigraphy. Am J Cardiol 69(8):780–784
Kuschnir E, Kustich F, Epelman M, Santamarina N, Podio R (1974) Valoración del flujo miocádico con Rb 86 en pacientes con cariopatía Chagásica, con insuficiencia coronaria y en controles normales. Parte I: estudios basales. Arq Bras Cardiol 27:187–96.
Castro R, Kuschnir E, Cardiol HS (1988) Evaluacion de la performance cardiaca y perfusion miocardica con radiotrazadores en la cardiopatia chagasica cronica. Rev Fed Arg 17:226–231
Hiss FC, Lascala TF, Maciel BC, Marin-Neto JA, Simões MV (2009) Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas’ cardiomyopathy. JACC Cardiovasc Imaging 2(2):164–172
Volpe GJ, Moreira HT, Trad HS, Wu K, Braggion-Santos M, Santos M et al (2014) Presence of scar by late gadolinium enhancement is a strong predictor of events in Chagas Heart Disease. J Cardiovasc Magn Reson 16(Suppl 1):P343
Rassi A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG et al (2006) Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med 355(8):799–808
Mavrogeni S, Petrou E, Kolovou G, Theodorakis G, Iliodromitis E (2013) Prediction of ventricular arrhythmias using cardiovascular magnetic resonance. Eur Hear J - Cardiovasc Imaging 14(6):518–525
Senra T, Ianni BM, Costa ACP, Mady C, Martinelli-Filho M, Kalil-Filho R et al (2018) Long-term prognostic value of myocardial fibrosis in patients with Chagas cardiomyopathy. J Am Coll Cardiol 72(21):2577–2587
Fuenmayor AJ, Fuenmayor AM, Carrasco H, Parada H, Fuenmayor C, Jugo D (1997) Results of electrophysiologic studies in patients with acute Chagasic myocarditis. Clin Cardiol 20(12):1021–1024
Healy C, Viles-Gonzalez JF, Sáenz LC, Soto M, Ramírez JD, D’Avila A (2015) Arrhythmias in Chagasic cardiomyopathy. Card Electrophysiol Clin 7(2):251–268
Martinelli Filho M, De Siqueira SF, Moreira H, Fagundes A, Pedrosa A, Nishioka SD et al (2000) Probability of occurrence of life-threatening ventricular arrhythmias in Chagas’ disease versus non-Chagas’ disease. Pacing Clin Electrophysiol 23(11 Pt 2):1944–1946
Carrasco HA, Guerrero L, Parada H, Molina C, Vegas E, Chuecos R (1990) Ventricular arrhythmias and left ventricular myocardial function in chronic chagasic patients. Int J Cardiol 28(1):35–41
de Andrade JP, Marin Neto JA, de Paola AAV, Vilas-Boas F, Oliveira GMM, Bacal F et al (2011) I Diretriz Latino-Americana para o diagnóstico e tratamento da cardiopatia chagásica: resumo executivo. Arq Bras Cardiol 96(6):434–442
Milei J, Pesce R, Valero E, Muratore C, Beigelman R, Ferrans VJ (1991) Electrophysiologic-structural correlations in chagasic aneurysms causing malignant arrhythmias. Int J Cardiol 32(1):65–73
Takehara K, Scanavacca MI, Sosa E, Lopes E, Barbero Marcial ML, Consolim FM, et al (1990) Aspectos anatomo-patológicos do foco da taquicardia ventricular sustentada recorrente da miocardiopatia chagásica cronica. Arq Bras Cardiol 55(Suppl. b):B68
Scanavacca M (2014) Epicardial ablation for ventricular tachycardia in chronic Chagas heart disease. Arq Bras Cardiol 102(6):524–528
Sosa E, Scalahini A, Rati M, Bellotti G, Pileggi F (1988) Successful catheter ablation of the origin of recurrent ventricular tachycardia in chronic chagasic heart disease. J Electrophysiol 1(1):58–61
Rosas F, Velasco V, Arboleda F, Santos H, Orjuela H, Sandoval N et al (1997) Catheter ablation of ventricular tachycardia in Chagasic cardiomyopathy. Clin Cardiol 20(2):169–174
Sosa E, Scanavacca M, d’Avila A, Pilleggi F (1996) A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol 7(6):531–536
Sosa E, Scanavacca M, D’Avila A, Piccioni J, Sanchez O, Velarde JL et al (1998) Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia. J Cardiovasc Electrophysiol 9(3):229–239
Henz BD, Do Nascimento TA, Dietrich CDO, Dalegrave C, Hernandes V, Mesas CE et al (2009) Simultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent ICD shocks in chronic chagasic cardiomyopathy. J Interv Card Electrophysiol 26(3):195–205
Pisani CF, Romero J, Lara S, Hardy C, Chokr M, Sacilotto L et al (2020) Efficacy and safety of combined endocardial/epicardial catheter ablation for ventricular tachycardia in Chagas disease: a randomized controlled study. Hear Rhythm. https://doi.org/10.1016/j.hrthm.2020.02.009
Nunes MCP, Dones W, Morillo CA, Encina JJ, Ribeiro AL (2013) Council on Chagas disease of the Interamerican Society of Cardiology. Chagas Dis J Am Coll Cardiol 62(9):767–776
Funding
No funding was received for the making of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Disclaimer: The views expressed in this article are the authors’ own views and not an official position of an institution.
Rights and permissions
About this article
Cite this article
Duran-Crane, A., Rojas, C.A., Cooper, L.T. et al. Cardiac magnetic resonance imaging in Chagas’ disease: a parallel with electrophysiologic studies. Int J Cardiovasc Imaging 36, 2209–2219 (2020). https://doi.org/10.1007/s10554-020-01925-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-020-01925-2